May 15 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO
* Nuvo Pharmaceuticals announces district court decision to uphold U.S. Pennsaid 2% patent
* Court upheld validity of Horizon Pharma's U.S. patent covering Pennsaid 2%
* Pennsaid 2% has multiple orange book listed patents with terms that extend to 2030 Source text for Eikon: Further company coverage: NRI.TO